Josef Lichtmannegger Selected Research

Josef Lichtmannegger Research Topics

14	Hepatolenticular Degeneration (Wilson's Disease) 07/2023 - 02/2003
3	Hepatitis 01/2011 - 03/2004
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2019 - 01/2016
2	Inborn Genetic Diseases (Disease, Hereditary) 09/2018 - 02/2009
2	Liver Diseases (Liver Disease) 09/2013 - 10/2003
2	Hepatocellular Carcinoma (Hepatoma) 07/2013 - 02/2008
1	Drug-Related Side Effects and Adverse Reactions 07/2023
1	Fatty Liver 01/2019
1	Neuroblastoma 09/2018
1	Massive Hepatic Necrosis 01/2016
1	Disease Progression 05/2014
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2013
1	Liver Failure 04/2011
1	Body Weight (Weight, Body) 01/2011

14	CopperIBA 07/2023 - 02/2003
4	methanobactinIBA 07/2023 - 01/2011
3	Chelating AgentsIBA 01/2022 - 03/2004
3	Proteins (Proteins, Gene)FDA Link 09/2018 - 02/2008
3	tetrathiomolybdate (ammonium tetrathiomolybdate)IBA 02/2009 - 02/2003
2	Copper-Transporting ATPasesIBA 01/2016 - 04/2011
2	DioxinsIBA 07/2013 - 02/2008
2	Polychlorinated Dibenzodioxins (TCDD)IBA 07/2013 - 02/2008
1	Sulfhydryl Compounds (Thiols)IBA 09/2018
1	Taurochenodeoxycholic AcidIBA 09/2013
1	Glycochenodeoxycholic Acid (Glycochenodeoxycholate)IBA 09/2013
1	Bile Acids and Salts (Bile Acids)IBA 09/2013
1	ursodoxicoltaurineIBA 09/2013
1	Insulin-Like Growth Factor Binding Protein 4IBA 07/2013
1	ZincIBA 02/2009
1	ProteomeIBA 02/2008
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2008
1	IsotopesIBA 02/2008
1	IronIBA 03/2004
1	MetalsIBA 10/2003
1	MolybdenumIBA 02/2003

1	Drug Substitution 07/2023
1	Liver Transplantation 01/2016
1	Therapeutics 12/2013
1	Chelation Therapy (Therapy, Chelation) 02/2009